Synaptogenix to Present at the Cell Symposium
/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...
Comunidad Autonoma De Cataluna Daniel Alkon Robert Weinstein Exchange Commission National Institutes Of Health Drug Administration
Source: prnewswire.com